{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:44:23Z","timestamp":1648734263670},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8041","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T18:11:37Z","timestamp":1494785497000},"page":"1157-1161","source":"Crossref","is-referenced-by-count":1,"title":["Multifocal Colonic Wall Abscesses during Anti-Tumor Necrosis Factor (TNF)-\u03b1 Therapy for a Patient with Ulcerative Colitis: A Very Rare Manifestation of Infectious Complications"],"prefix":"10.2169","volume":"56","author":[{"given":"Toshiro","family":"Fukui","sequence":"first","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Takahashi","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okazaki","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tomiyama","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Fukata","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Ando","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuichi","family":"Okazaki","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brennan FM, Maini RN, Feldmann M. TNF alpha--a pivotal role in rheumatoid arthritis? Br J Rheumatol 31: 293-298, 1992.","DOI":"10.1093\/rheumatology\/31.5.293"},{"key":"2","unstructured":"2. Matsuoka K, Hibi T. Treatment guidelines in inflammatory bowel disease: the Japanese perspectives. Dig Dis 31: 363-367, 2013."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Amiot A, Peyrin-Biroulet L. Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases. Therap Adv Gastroenterol 8: 66-82, 2015.","DOI":"10.1177\/1756283X14558193"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Infect Dis Clin North Am 24: 285-306, 2010.","DOI":"10.1016\/j.idc.2010.01.006"},{"key":"5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"5. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134: 929-936, 2008.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sousa P, Allez M. Complications of biologics in inflammatory bowel disease. Curr Opin Gastroenterol 31: 296-302, 2015.","DOI":"10.1097\/MOG.0000000000000191"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stallmach A, Hagel S, Bruns T. Adverse effects of biologics used for treating IBD. Best Pract Res Clin Gastroenterol 24: 167-182, 2010.","DOI":"10.1016\/j.bpg.2010.01.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis 27: 555-559, 2009.","DOI":"10.1159\/000233297"},{"key":"9","unstructured":"9. Lees CW, Ali AI, Thompson AI, et al. The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. Aliment Pharmacol Ther 29: 286-297, 2009."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Becker JM, Stucchi AF. Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy. Inflamm Bowel Dis 15: 146-149, 2009.","DOI":"10.1002\/ibd.20780"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamada T, Sasatomi E, Sato T, et al. Phlegmonous colitis in a patient with liver cirrhosis, hepatocellular carcinoma and acute promyelocytic leukemia. Intern Med 34: 542-545, 1995.","DOI":"10.2169\/internalmedicine.34.542"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Holzer T, Gervaz P, Spahr L, et al. Phlegmonous colitis: another source of sepsis in cirrhotic patients? BMC Gastroenterol 9: 94, 2009.","DOI":"10.1186\/1471-230X-9-94"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pang SH, de Silva K, Napoli J, et al. A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy. Intern Med J 39: 481-484, 2009.","DOI":"10.1111\/j.1445-5994.2009.01919.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.8041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:39:32Z","timestamp":1569328772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.8041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8041","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}